News | Press Releases

---

July 26, 2017

Moffitt Cancer Center Enhances Patient Care with Toshiba Medical’s Innovative Merging of IR and CT

Infinix-i 4D CT Streamlines Workflow So Clinicians Can Offer Faster and Safer Exams to More Patients

TUSTIN, Calif., July 26, 2017 – Cancer patients at Moffitt Cancer Center in Tampa, Fla., now have access to advanced diagnostic imaging for fast and safe exams with the facility’s Infinix^TM-i 4D CT system from Toshiba Medical, a Canon Group company. Moffitt, one of the nation’s leading cancer hospitals, is the first healthcare provider in the state of Florida to use the system’s innovative merging of the Infinix-i angiography system and Aquilion^TM PRIME CT system for interventional radiology (IR) and oncology procedures. The system may help clinicians improve visualization and workflow and increase patient safety. A ribbon-cutting ceremony was held on July 25 to mark the occasion.

Moffitt is using the Infinix-i 4D CT for a variety of IR and oncology procedures to more efficiently plan, treat and verify in a single clinical setting. The system’s seamless integration of the interventional lab and CT scanner can transform workflow, eliminating the need to transfer patients between departments, decreasing procedure time and maintaining patient safety.

“Time is critical when treating cancer patients, and we acquired the Infinix-i 4D CT to help us provide faster and safer care to more patients,” said Grace Cabral, Patient Care Manager of Interventional Radiology at Moffitt. “With the new system we can capture high-quality images more quickly than before without having to transfer patients between machines, which has allowed us to double our embolization case load and significantly reduce wait times for ablations and biopsies. Additionally, the system’s small footprint allowed us to install the Infinix-i 4D CT quickly, with little downtime for construction, so we could begin utilizing it with patients right away.”

The Infinix-i enables clinicians to provide precision and flexibility during intervention with fingertip-to-fingertip and head-to-toe coverage and enables unprecedented patient access with the Access Halo. As a true CT system, the Aquilion PRIME produces image quality that far exceeds CT-like imaging of the interventional lab. Toshiba Medical’s third-generation iterative dose reconstruction software, AIDR 3D Enhanced, offers simplified CT dose reduction, while the Infinix-i has a suite of dose management features including the Dose Tracking System.

“We designed the Infinix-i 4D CT as a complete imaging solution to address our customers’ need for efficiency without compromising safety,” said Satrajit Misra, vice president, Marketing and Strategic Development, Toshiba America Medical Systems, Inc. “At Moffitt Cancer Center, we are seeing this goal come to life by one of the nation’s premier cancer treatment centers significantly expanding its imaging capabilities and offering more patients the exceptional care Moffitt is known for.”

About Toshiba America Medical Systems, Inc.

Toshiba America Medical Systems, a Canon Group company headquartered in Tustin, Calif., markets, sells, distributes and services radiology and cardiovascular systems, including CT, MR, ultrasound, X-ray and interventional X-ray equipment. For more information, visit Toshiba Medical’s website at www.medical.toshiba.com.

About Toshiba Medical

Toshiba Medical offers a full range of diagnostic medical imaging solutions including Ultrasound, CT, X-Ray, and MR, across the globe. As of December 2016, Toshiba Medical became a member of the Canon Group. In line with our continued Made for Life philosophy, patients are at the heart of everything we do. Our mission is to provide medical professionals with solutions that support their efforts in contributing to the health and wellbeing of patients worldwide so that together our industry-leading solutions deliver an enriched quality of life.

About Moffitt Cancer Center

Moffitt is dedicated to one lifesaving mission: to contribute to the prevention and cure of cancer. The Tampa-based facility is one of only 48 National Cancer Institute-designated Comprehensive Cancer Centers, a distinction that recognizes Moffitt’s excellence in research, clinical trials, prevention and cancer control. Moffitt is the No. 6 cancer hospital in the nation and has been listed in U.S. News & World Report as one of the “Best Hospitals” for cancer care since 1999. Moffitt devotes more than 2 million square feet to research and patient care. Moffitt’s expert nursing staff is recognized by the American Nurses Credentialing Center with Magnet^® status, its highest distinction. With more than 5,600 team members, Moffitt has an economic impact in the state of $2.1 billion. For more information, call 1-888-MOFFITT (1-888-663-3488), visit MOFFITT.org, and follow the momentum on Facebook, Twitter and YouTube.